Liquidity & Technical

Liquidity & Technical

Figures converted from EUR at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

Auto1 trades $12.9M per day on a $5.8B market cap — workable for specialist mid-cap funds but capacity-constrained for any large institutional book. The tape sits in a textbook tactical-bullish / structural-bearish split: a fresh death cross on 17 Feb 2026 marked the start of a sub-200d regime, then price ripped +43% in three months off the panic low. Whether the bounce sticks above $28 or fails into the $21 shelf decides the next 3–6 months.

1. Portfolio implementation verdict

2. Price snapshot

Down on the year, down on the prior twelve months, but up 43% in three months — the price strip captures the regime change perfectly: a stock recovering from a violent re-rating, not yet reclaimed. Beta versus a developed-market benchmark is not reliably estimable because the rebase file contains no benchmark series for this German listing.

3. Price with 50-day and 200-day SMA — full history since IPO

Price is 4.6% below the 200-day SMA ($26.54 vs $27.82). This is a downtrend regime tactically reclaiming the 50-day. The long-history view tells the truer story: AG1 IPO'd at $65 in Feb 2021, lost 94% over three years to a $3.57 low in February 2024, then ran +900% to $35 by late 2025 before re-rating −47% in the Feb 2026 break. The current bounce is mean-reversion off an extreme — it has not yet repaired the November–February damage.

4. Relative performance — no benchmark series staged

The shape matters more than the absent benchmark. AG1 went from 100 → 377 in 28 months (a six-bagger from the post-pandemic carnage), then surrendered roughly half the gain in a single Feb 2026 dislocation, then bounced. A peer or benchmark line would show whether the re-rating is company-specific or sector-wide; the cleanly idiosyncratic February drop suggests company-specific (likely guidance- or print-driven). Cross-reference the Catalysts tab before sizing.

5. Momentum panel — RSI(14) and MACD histogram

RSI sits at 64, MACD histogram at +0.07 and decelerating from the +0.70 April peak. Read together: the bounce off the February panic (RSI bottomed at 21 on 13 Feb 2026) has carried into mid-range RSI territory, but momentum is rolling — the histogram has compressed seven sessions in a row from +0.32 to +0.07. Near-term call is constructive but tiring: the rally that delivered +43% in three months is asking for the next catalyst to push RSI above 70, not extend the move by inertia.

6. Volume, volatility, and sponsorship

Realized vol has collapsed from 88% in March 2026 to 54% — back at the 5-year median (p50 = 53.5%). Translation: the Feb 2026 panic has been worked off, but this stock is not a low-vol vehicle even when calm — its calm baseline is twice that of an index name. The 25 Feb 2026 session — $18.65 close, −18.2% on 6.8× average volume — was the watershed event. Recent rally sessions show volume running above the 50-day average through April and May 2026, which is constructive: this is sponsored buying, not a drift higher on thin air.

7. Institutional liquidity panel

A. ADV and turnover

B. Fund capacity at conventional position weights

A fund of $706M can establish a 2% position in five trading days at the aggressive 20%-ADV participation; at the conservative 10%-ADV pace that same fund halves to $353M. A 5% position caps the supported fund at $282M (aggressive) or $141M (conservative). Above those ceilings, you are the price — and post-trade markouts will reflect it.

C. Liquidation runway for issuer-sized positions

D. Intraday range proxy

Median daily true range over the last 60 sessions is 1.97% — close to the 2% threshold where order-book impact starts to bite for size. Slippage on block executions should be modeled, not assumed away.

The 5-day clearance bar: the largest position that clears in five trading days at 20% ADV is ≈ 0.24% of market cap ($14M); at the conservative 10% ADV it halves to ≈ 0.12% ($7M). Anything beyond 1% of market cap requires three weeks of patient execution at 20% ADV, or twice that at 10%.

8. Technical scorecard and stance

Stance: tactically constructive, structurally cautious — net +2 over a 3-to-6 month horizon. The setup since the February panic — RSI reset from 21, recovery on rising volume, SMA50 reclaimed — leaves the SMA200 at $27.82 as the next test level. The trade triggers are clean:

• Bullish confirmation: a daily close above $28.50 — reclaims the 200-day SMA and the breakdown level from the Feb gap; unlocks a path toward the $33–34 supply zone (Nov 2025 distribution shelf).
• Bearish invalidation: a daily close below $21.00 — breaks the SMA50 ($22.28) and the lower Bollinger Band; reopens the Feb low ($17.03) and re-establishes the death-cross downtrend.

Liquidity is the constraint for institutional sizing, not for the trade itself. For specialist mid-cap funds under $580M of AUM, this is implementable. For larger funds, the correct action is watchlist with a slow-build mandate — average in over 4–6 weeks at 10% ADV participation, sized to no more than 1% of book to keep exit runway under three weeks.